Both in Pharmaceuticals
Veradermics, Incorporated vs Oruka Therapeutics
Over the past year MANE returned +251.3% and ORKA returned +202.8%; their daily moves had a correlation of 0.26.
MANE +251.3% ORKA +202.8%Growth of $1, one year, split-adjusted
| Metric | MANE | ORKA |
|---|---|---|
| Price | $133.61 | $99.55 |
| Market cap | $5.58B | $6.59B |
| Today | +3.15% | +4.32% |
| 1 month | +12.4% | +18.0% |
| 6 months | +16.4% | +44.4% |
| Year to date | — | +228.4% |
| 1 year | — | +253.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $819.9M | $873.6M |
| Dividend yield | — | — |
| Volatility (60d) | 63.8% | 51.7% |
| Short % of float | 15.2% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).